Your browser doesn't support javascript.
loading
Preoperative Peak Oxygen Consumption: A Predictor of Survival in Resected Lung Cancer.
Lindenmann, Joerg; Fink-Neuboeck, Nicole; Fediuk, Melanie; Maier, Alfred; Kovacs, Gabor; Balic, Marija; Smolle, Josef; Smolle-Juettner, Freyja Maria.
Afiliación
  • Lindenmann J; Division of Thoracic Surgery and Hyperbaric Surgery, Department of Surgery, Medical University of Graz, 8036 Graz, Austria.
  • Fink-Neuboeck N; Division of Thoracic Surgery and Hyperbaric Surgery, Department of Surgery, Medical University of Graz, 8036 Graz, Austria.
  • Fediuk M; Division of Thoracic Surgery and Hyperbaric Surgery, Department of Surgery, Medical University of Graz, 8036 Graz, Austria.
  • Maier A; Division of Thoracic Surgery and Hyperbaric Surgery, Department of Surgery, Medical University of Graz, 8036 Graz, Austria.
  • Kovacs G; Division of Pulmonology, Department of Internal Medicine, Medical University of Graz, 8036 Graz, Austria.
  • Balic M; Ludwig Boltzmann Institute for Lung Vascular Research, 8036 Graz, Austria.
  • Smolle J; Division of Oncology, Department of Internal Medicine, Medical University of Graz, 8036 Graz, Austria.
  • Smolle-Juettner FM; Institute of Medical Informatics, Statistics and Documentation, Medical University of Graz, 8036 Graz, Austria.
Cancers (Basel) ; 12(4)2020 Mar 31.
Article en En | MEDLINE | ID: mdl-32244329
ABSTRACT
The peak oxygen consumption (VO2 peak) serves as a prognostic factor in cardio-respiratory diseases and plays an important role in cancer patients. The long-term prognostic relevance of VO2 peak in lung cancer patients has not been investigated extensively. The aim of this study was to evaluate the impact of the preoperative VO2 peak on the postoperative long-term survival in patients with operated lung cancer. Retrospective analysis of 342 patients with curatively resected non-small-cell lung cancer using a multivariate Cox proportional hazard model.

Results:

Preoperative VO2 peak ranged from 10.2 to 51.8 mL/kg/min (mean 18.3 ± 4.6), VO2 peak % of predicted ranged from 32 to 172% (mean 65.2 ± 18.0%). Overall 10-year survival was 23%. A Log-rank test comparing predicted VO2 peak ≥ 60% with predicted VO2 peak < 60% showed overall survival of 30% and 17%, respectively (p < 0.001) and non-tumour-related survival of 71% and 51% (p = 0.001) at 10 years. In multivariable Cox analysis, overall 10-year survival correlated with a high predicted VO2 peak% (p = 0.001) and low N-stage corresponding to N0 and N1 (p < 0.001). Non-tumour-related death correlated with low VO2 peak% of predicted (p = 0.001), and age (p < 0.001). Low preoperative VO2 peak was associated with both decreased postoperative overall survival and decreased non-tumour-related survival during the 10-year follow-up.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2020 Tipo del documento: Article País de afiliación: Austria

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Año: 2020 Tipo del documento: Article País de afiliación: Austria